Aktuella utlysningar, vecka 14, 2019
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska utlysningar
Cancerfonden - Swedish Cancer Society
Dessa stöder forskningsprojekt inom alla former av cancerforskning, genom att tillhandahålla medel för driftkostnader, inköp av material och utrustning, samt till personal. Anslag uppgår till SEK 2.5 miljoner per år i upp till tre år.
Forskarmånader för kliniskt verksamma
Dessa avser att bereda möjlighet för cancerforskare med klinisk tjänstgöring inom medicinsk-, vård-, samhälls- och beteendevetenskaplig verksamhet att avsätta tid för forskning. Bidrag uppgår till SEK 140,700 per månad i mellan en och tre månader per år, under högst tre år.
Bidrag för planeringsgrupper
Detta syftar till att sammanföra forskargrupper och forskare med likartad metodologisk eller ämnesmässig tillhörighet, för att öka samarbete och informationsutbyte och att underlätta planering av flercenterstudier. Avdrag för indirekta kostnader uppgår till 15,25 procent av anslaget.
Closing date: 25 April 2019
Bidrag för forskning och utvecklingsarbete – Norrbacka-Eugeniastiftelsen
Norrbacka-Eugeniastiftelsen inbjuder ansökningar om bidrag för forskning och utvecklingsarbete. Dessa stöder grundforskning och utvecklingsarbete rörande personer med varaktig fysisk rörelsenedsättning. Bidrag uppgår till SEK 300,000 per år.
Closing date: 30 April 2019
Reumatologiskt pris till Nanna Svartz minne – Swedish Rheumatism Association
Detta syftar till att uppmuntra patientnära forskning i Sverige, samt att öka intresse och kännedom om den reumatologiska forskningen bland sjukvårdspersonal, beslutsfattare och allmänhet. Prissumman uppgår till SEK 150,000 och kan delas mellan flera personer som samarbetat kring den stipendiebelönade insatsen.
Closing date: 30 April 2019
Bidrag för forskning och utvecklingsarbete inom funktionshinder – Stiftelsen Sunnerdahls Handikappfond
Dessa stöder samhällsvetenskaplig, pedagogisk och medicinsk forskning kring barn och ungdomar med funktionshinder. Den totala budgeten uppgår till SEK 2 miljoner. Bidrag ges i regel till mellan tio till femton projekt och uppgår till SEK 200,000.
Closing date: 30 April 2019
Eric K Fernström's Nordic prize – Lund University
This recognises researchers based at Nordic institutes for their scientific work in the field of medicine. The award is worth SEK 1 million and may be shared between up to three winners.
Closing date: 30 April 2019
Endocrinology research and metabolism grants – Nordic region Novo Nordisk Foundation
The Novo Nordisk Foundation invites applications for its project grants in endocrinology and metabolism – Nordic region. These support established scientists in carrying out research projects in endocrinology and metabolism relating to cellular energy homeostasis. Research activities must take place at a university, hospital or other non-profit research institution in Denmark, Finland, Iceland, Norway or Sweden. The principal investigator should be the main applicant and be established in their field of research, or be a researcher that is in the process of establishing themselves as an independent researcher. The total budget is worth up to DKK 80 million. Grants are worth between DKK 300,000 and DKK 1m per year for one to three years.
Closing date: 4 June 2019
Start-up grants for young researchers, SSMF Large Grants – The Swedish Society for Medical Research (Svenska Sällskapet för Medicinsk Forskning, SSMF)
SSMF announces 4-year start-up grants to support young researchers working full- or half-time. Half-time grants are intended for clinically active researchers. Start-up support is awarded for 2 years with a 2-year extension after approval of a scientific report. The objective is to offer promising young scientists an opportunity to establish themselves as independent researchers. The person who holds or at the time of application has been assigned a teaching service (research assistant, assistant professor, associate professor, professor) or multi-annual research service funded by national or international funding providers is not authorized to apply. Full-time: Qualifying candidates are those who have obtained a doctorate at least 2 and no more than 7 years before the end of the application period. Clinical half-time: Applicants are eligible by having obtained a doctorate no more than 10 years before the end of the application period.
Closing date: 15 May 2019
Networking project grants - European Society for Paediatric Gastroenterology, Hepatology and Nutrition
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition invites submissions for its networking project grants. These enable members to undertake research activities and network among centres at an international level. Activities may include interactive educational events and clinical networks. Proposals relevant to the society’s activities, such as the validation of guidelines, or clinical networks for testing treatment regimes or disease management, are encouraged.
Main applicants must be members of the society and all projects must include more than one country. Non-society members may participate in collaboration with society members. Five grants, worth up to €50,000 each, are available.
Closing date: 31 July 2019
Workshops - European Molecular Biology Organisation
The European Molecular Biology Organisation invites applications for its grants to support workshops. These enable the organisation of workshops that cover different and evolving aspects of life-science related subject areas, and bring scientists together to present their findings.
Workshops must take place in an EMBC members state, an EMBC associate member state or cooperating partner countries. In rare cases, EMBO may consider applications for workshops taking place in other regions of the world. Up to €37,000 is available per workshop
Closing date: 1 August 2019
Project grants - European Society of Contraception and Reproductive Health
The European Society of Contraception and Reproductive Health invites applications for its project grants. These support an individual, group, institute or organisation with a scientific project related to the aims of the ESC. Projects may include research into methods or provision of contraception, sexual and reproductive health, validated questionnaires to understand uptake or utilisation of a method or procedure or a needs assessment within a community or locale.
European ESC members may apply. Projects may take place outside Europe. Grants are worth up to €10,000 each.
Closing date: 30 June 2019
Quest for cures – collaborative discovery teams: Brain Tumour Charity
The Brain Tumour Charity invites letters of intent for its collaborative discovery teams grants. These aim to foster a collaborative research process, strengthen ties between basic and clinical research and promote transformational brain tumour research advances with the potential for rapid clinical translation. The teams should seek innovative approaches to address the critical questions that could present a paradigm shift for brain tumour research or use unexplored paths to allow for new discoveries to be made. Projects should be preclinical studies.
Applicant teams must include both established and promising researchers from multidisciplinary backgrounds. The collaborative team must have the relevant expertise of laboratory and clinical researchers to demonstrate how discoveries will be translated and taken forward to patient benefit. The call is open to international researchers, but applications including a UK collaborator will be looked on favourably. Funding is worth £1.5 million per programme over five years.
Closing date: 24 June 2019
Federal Funding agencies
Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional): NIH
The objective of this FOA is to advance non-sputum-based tuberculosis (TB) diagnostics for use in HIV-1 infected and HIV-1 exposed uninfected children (HEU) for improved, simplified, rapid and decentralized diagnosis of TB disease. This opportunity will support discovery and validation of novel biomarkers useful for TB diagnosis or the development/optimization and early validation of novel TB diagnostic technologies.
Closing date: July 30, 2019, by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-AI-19-036
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field. Potential applicants who are interested in downstream technology development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.
Closing date: June 11, 2019; November 20, 2019), by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-CA-19-038
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed): NIH
The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. This FOA is designed to facilitate activities central to the refinement of a study protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures or document recruitment potential. The grant must not be used to generate data on the effects of a proposed intervention. This NEI FOA is applicable to both epidemiologic and clinical trial research studies.
Closing date: Standard dates apply by 5:00 PM local time of applicant organization until May 8, 2022.
Funding Opportunity Announcement (FOA): PAR-19-231
Peer Reviewed Cancer Research Program (PRCRP): DOD
The goal of the PRCRP is to improve mission readiness and quality of life by decreasing the burden of cancer on Service members, their families, and the American public. The FY19 appropriation is $90 million (M).
All applications for PRCRP funding must specifically address at least one of the Topic Areas as directed by Congress and must be of clear scientific merit and direct relevance to military health. The FY19 PRCRP Topic Areas are listed below:
•Bladder cancer • Blood cancers • Brain cancer • Cancer in children, adolescents, and young adults • Colorectal cancer • Immunotherapy • Listeria vaccine for cancer • Liver cancer • Lymphoma • Mesothelioma • Neuroblastoma • Pancreatic cancer • Pediatric brain tumors • Rare cancers • Stomach cancer
New for FY19: Studies involving melanoma (including rare subtypes of melanoma) should apply to the new FY19 Melanoma Research Program. Studies involving other skin cancers will be accepted by the PRCRP under an appropriate FY19 PRCRP Topic Area (i.e., immunotherapy)
Closing date: Career Development Award (LOI: August 21, Full Application: September 11); Horizon Award (LOI: August 21, Full Application: September 11); Idea Award with Special Focus (LOI: May 22 , Full Application: September 11); Impact Award (LOI: May 22 , Full Application: September 11); Translational Team Science Award (LOI: May 22 , Full Application: September 11).
Funding Opportunity Announcement (FOA): Career Development Award (W81XWH-19-PRCRP-CDA); Horizon Award (W81XWH-19-PRCRP-HA); Idea Award with Special Focus (W81XWH-19-PRCRP-IASF); Impact Award (W81XWH-19-PRCRP-IPA); Translational Team Science Award (W81XWH-19-PRCRP-TTSA).
Lung Cancer Research Program (LCRP): DOD
The goal of the FY19 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of the military Service members, Veterans, and the American public. The FY19 appropriation is $14 million (M).
To be considered for funding, applications for the FY19 LCRP Career Development Award must address at least one of the nine Areas of Emphasis listed below:
• Identify innovative strategies for the screening and early detection of lung cancer. • Understand the molecular mechanisms of initiation and progression to clinically significant lung cancer. • Identify innovative strategies for prevention of the occurrence of lung cancer. • Identify innovative strategies for the treatment of lung cancer. • Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer. DoD FY19 Lung Cancer Career Development Award 4 • Develop or optimize predictive markers to assist with therapeutic decision-making. • Understand mechanisms of resistance to treatment (primary and secondary). • Understand contributors to lung cancer development other than tobacco. • Identify innovative strategies for lung cancer care delivery (clinical management/ surveillance/symptom management).
Closing date: Career Development Award (LOI: August 1, Full Application: August 21); Idea Development Award (LOI: May 15, Full Application: August 21); Investigator-Initiated Translational Research Award (LOI: May 15, Full Application: August 21); Translational Team Science Award (LOI: May 15, Full Application: August 21).
Funding Opportunity Announcement (FOA): Career Development Award (W81XWH-19-LCRP-CDA); Idea Development Award (W81XWH-19-LCRP-IDA); Investigator-Initiated Translational Research Award (W81XWH-19-LCRP-IITRA); Translational Research Partnership Award (W81XWH-19-LCRP-TRPA).
Summer 2019 Pilot Award- Request for Applications, Simons Foundation, US
Grants awarded through this RFA are intended to provide early support for exploratory ideas, particularly those with novel hypotheses for autism. Appropriate projects for this mechanism include those considered higher risk with less assurance of ultimate impact, but with the potential for transformative results.
Investigators new to the field of autism are encouraged to apply for these awards. The total budget of a Pilot Award is $300,000 or less, including 20 percent indirect costs, over a period of up to two (2) years.
Closing date: April 18, 2019.